Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and sleep hygiene added to usual ADHD treatment in patients with sleep phase delay syndrome
IRCT20211004052670N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in attention deficit hyperactivity disorder (ADHD) and circadian rhythm sleep disorder (CRSD), sponsored by Isfahan University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)circadian rhythm sleep disorder (CRSD)
Beyond the preview
Go deeper on IRCT20211004052670N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211004052670N5.